|
 
 |
| ERRATUM |
|
| Year : 2018 | Volume
: 14
| Issue : 2 | Page : 478 |
|
Erratum: Dosimetric properties of new formulation of PRESAGE® with tin organometal catalyst: Development of sensitivity and stability to megavoltage energy
| Date of Web Publication | 8-Mar-2018 |
Correspondence Address:
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0973-1482.226733
How to cite this article:
. Erratum: Dosimetric properties of new formulation of PRESAGE® with tin organometal catalyst: Development of sensitivity and stability to megavoltage energy. J Can Res Ther 2018;14:478 |
How to cite this URL:
. Erratum: Dosimetric properties of new formulation of PRESAGE® with tin organometal catalyst: Development of sensitivity and stability to megavoltage energy. J Can Res Ther [serial online] 2018 [cited 2023 Jan 27];14:478. Available from: https://www.cancerjournal.net/text.asp?2018/14/2/478/226733 |
In the article titled, “Dosimetric properties of new formulation of PRESAGE® with tin organometal catalyst: Development of sensitivity and stability to megavoltage energy”, DOI 10.4103/0973-1482.183550 of Journal of Cancer Research and Therapeutics,[1] the affiliation of author Nooshin Banaee is written incorrectly as “Department of Engineering, Science and Research Branch, Islamic Azad University, Tehran, Iran” instead of “Department of Medical Radiation Engineering, Central Tehran Branch, Islamic Azad University, Tehran, Iran.”
| > References | |  |
| 1. | Khezerloo D, Nedaie HA, Takavar A, Zirak A, Farhood B, Banaee N, Alidokht E Dosimetric properties of new formulation of PRESAGE ® with tin organometal catalyst: Development of sensitivity and stability to megavoltage energy. J Can Res Ther 2016. [DOI: 10.4103/0973-1482.183550]. [Epub ahead of print].  |
|
